<!DOCTYPE html>
  <!--[if IEMobile 7]><html class="no-js ie iem7 not-responsive" lang="en" dir="ltr"><![endif]-->
  <!--[if lte IE 6]><html class="no-js ie lt-ie9 lt-ie8 lt-ie7 not-responsive" lang="en" dir="ltr"><![endif]-->
  <!--[if (IE 7)&(!IEMobile)]><html class="no-js ie lt-ie9 lt-ie8 not-responsive" lang="en" dir="ltr"><![endif]-->
  <!--[if IE 8]><html class="no-js ie lt-ie9 not-responsive" lang="en" dir="ltr"><![endif]-->
  <!--[if (gte IE 9)|(gt IEMobile 7)]><html class="no-js ie responsive" lang="en" dir="ltr" prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book# profile: http://ogp.me/ns/profile# video: http://ogp.me/ns/video# product: http://ogp.me/ns/product# content: http://purl.org/rss/1.0/modules/content/ dc: http://purl.org/dc/terms/ foaf: http://xmlns.com/foaf/0.1/ rdfs: http://www.w3.org/2000/01/rdf-schema# sioc: http://rdfs.org/sioc/ns# sioct: http://rdfs.org/sioc/types# skos: http://www.w3.org/2004/02/skos/core# xsd: http://www.w3.org/2001/XMLSchema#"><![endif]-->
  <!--[if !IE]><!--><html class="no-js responsive" lang="en" dir="ltr" prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book# profile: http://ogp.me/ns/profile# video: http://ogp.me/ns/video# product: http://ogp.me/ns/product# content: http://purl.org/rss/1.0/modules/content/ dc: http://purl.org/dc/terms/ foaf: http://xmlns.com/foaf/0.1/ rdfs: http://www.w3.org/2000/01/rdf-schema# sioc: http://rdfs.org/sioc/ns# sioct: http://rdfs.org/sioc/types# skos: http://www.w3.org/2004/02/skos/core# xsd: http://www.w3.org/2001/XMLSchema#"><!--<![endif]-->
<head>
  <title>Abbott Labs to Pay $1.5 Billion to Resolve Criminal &amp; Civil Investigations of Off-label Promotion of Depakote | OPA | Department of Justice</title>
  <!--[if IE]><![endif]-->
<meta charset="utf-8" />
<meta http-equiv="cleartype" content="on" />
<meta name="MobileOptimized" content="width" />
<link rel="shortcut icon" href="https://www.justice.gov/sites/default/files/favicon.png" type="image/png" />
<link rel="profile" href="http://www.w3.org/1999/xhtml/vocab" />
<link rel="apple-touch-icon-precomposed" href="https://www.justice.gov/sites/all/themes/justice/apple-touch-icon-precomposed.png" />
<link rel="apple-touch-icon-precomposed" href="https://www.justice.gov/sites/all/themes/justice/apple-touch-icon-precomposed-144x144.png" sizes="144x144" />
<script async="async" id="_fed_an_ua_tag" src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=DOJ&amp;sp=find&amp;yt=true&amp;subagency=opa"></script>
<link rel="apple-touch-icon-precomposed" href="https://www.justice.gov/sites/all/themes/justice/apple-touch-icon-precomposed-72x72.png" sizes="72x72" />
<meta name="HandheldFriendly" content="true" />
<link rel="apple-touch-icon-precomposed" href="https://www.justice.gov/sites/all/themes/justice/apple-touch-icon-precomposed-114x114.png" sizes="114x114" />
<meta name="viewport" content="width=device-width" />
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
<link rel="canonical" href="https://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote" />
<meta property="og:title" content="Abbott Labs to Pay $1.5 Billion to Resolve Criminal &amp; Civil Investigations of Off-label Promotion of Depakote" />
<meta property="og:description" content="Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company&amp;#8217;s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Justice Department announced today. The resolution &amp;#8211; the second largest payment by a drug company &amp;#8211; includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbott&amp;#8217;s CEO and Board of Directors." />
<meta property="og:image" content="https://www.justice.gov/sites/all/modules/features/doj_sharing/images/doj-seal-fb.jpg" />
<meta name="twitter:title" content="Abbott Labs to Pay $1.5 Billion to Resolve Criminal &amp; Civil Investigations of Off-label Promotion of Depakote" />
<meta name="twitter:description" content="Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company&amp;#8217;s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Justice Department announced today. The resolution &amp;#8211; the second largest payment by a drug company &amp;#8211; includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbott&amp;#8217;s CEO and Board of Directors." />
<meta name="twitter:image" content="https://www.justice.gov/sites/all/modules/features/doj_sharing/images/doj-seal-fb.jpg" />
  <link type="text/css" rel="stylesheet" href="https://www.justice.gov/sites/default/files/advagg_css/css__L9xBrWyh760kB07M33QP0YVvVMX64sk2-1FFDY8mDi4__048dHB8FVClU_xvw_jwAwb_WpKr0NqcM6EMUvrjSZNI__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.css" media="all" />

<!--[if lte IE 8]>
<link type="text/css" rel="stylesheet" href="https://www.justice.gov/sites/default/files/advagg_css/css__JQfwsVb8AHjJsxvkLORr8MKWY6kpVUNsHSIlUeHBziE__c440f7m3jDBbATa_fuiq9g0Wr5MNT4XqPpzO4WPT32Y__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.css" media="all" />
<![endif]-->
</head>
<body x-ms-format-detection="none" class="html not-front not-logged-in page-node page-node- page-node-55416 node-type-press-release og-context og-context-node og-context-node-1664 i18n-en section-opa one-sidebar sidebar-second og-context-office-of-public-affairs">
  <a id="skip-link" href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
    <div class="l-page not-panelized">
  <a name="page-top"></a>
  <div class="l-header-wrapper">
    <header class="l-header" role="banner">
      <div class="l-branding site-branding">
                  <a href="/" title="The United States Department of Justice" rel="home" class="site-branding__logo desktop"><img src="https://www.justice.gov/sites/default/files/logo.png" alt="The United States Department of Justice" /></a>
          <a href="/" title="The United States Department of Justice" rel="home" class="site-branding__logo mobile"><img src="https://www.justice.gov/sites/default/files/mobile-logo.png" alt="The United States Department of Justice" /></a>
        
              </div>

        <div class="l-region l-region--header">
    <div id="block-block-3" class="block block--block block--block-3">
        <h2 class="block__title">En Espanol</h2>
      <div class="block__content">
    <p><a style="display:block;" href="http://www.justice.gov/espanol">en Espaol</a></p>
  </div>
</div>
<div id="block-follow-site" class="block block--follow block--follow-site">
        <h2 class="block__title">Stay Connected with Justice:</h2>
      <div class="block__content">
    <div class='follow-links clearfix site'><span class='follow-link-wrapper follow-link-wrapper-twitter'><a href="http://www.twitter.com/TheJusticeDept" class="follow-link follow-link-twitter follow-link-site" title="Follow us on Twitter">Twitter</a>
</span><span class='follow-link-wrapper follow-link-wrapper-instagram'><a href="https://instagram.com/thejusticedept" class="follow-link follow-link-instagram follow-link-site" title="Follow us on Instagram">Instagram</a>
</span><span class='follow-link-wrapper follow-link-wrapper-facebook'><a href="http://www.facebook.com/DOJ" class="follow-link follow-link-facebook follow-link-site" title="Follow us on Facebook">Facebook</a>
</span><span class='follow-link-wrapper follow-link-wrapper-youtube'><a href="http://www.youtube.com/TheJusticeDepartment" class="follow-link follow-link-youtube follow-link-site" title="Follow us on YouTube">YouTube</a>
</span><span class='follow-link-wrapper follow-link-wrapper-this-site'><a href="/doj/news-feeds" class="follow-link follow-link-this-site follow-link-site" title="Follow us on RSS">RSS</a>
</span><span class='follow-link-wrapper follow-link-wrapper-newsletter'><a href="https://public.govdelivery.com/accounts/USDOJ/subscriber/new" class="follow-link follow-link-newsletter follow-link-site" title="Follow us on Email">Email</a>
</span></div>  </div>
</div>
<div id="block-usasearch-hosted-form" class="block block--usasearch-hosted block--usasearch-hosted-form">
        <div class="block__content">
    <form class="usasearch-hosted-box" action="https://search.justice.gov/search" method="get" id="usasearch-hosted-box" accept-charset="UTF-8"><div><div class="container-inline">
      <h2 class="element-invisible">Search form</h2>
    <div class="form-item form-type-textfield form-item-usasearch-hosted-box">
  <label class="element-invisible" for="edit-usasearch-hosted-box--2">Search </label>
 <input class="usagov-search-autocomplete ui-autocomplete-input ui-corner-all form-text" autocomplete="off" type="text" name="query" placeholder="Search this site" id="edit-usasearch-hosted-box--2" value="" size="15" maxlength="128" />
</div>
<div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="Search" class="form-submit" /></div><input type="hidden" name="affiliate" value="justice" />
</div>
</div></form>  </div>
</div>
<div id="block-nice-menus-1" class="block block--nice-menus block--nice-menus-1">
        <h2 class="block__title"><span class="nice-menu-hide-title">Main menu</span></h2>
      <div class="block__content">
    <ul class="nice-menu nice-menu-down nice-menu-main-menu" id="nice-menu-1"><li class="menu-1258 menu-path-front first odd "><a href="/" title="">Home</a></li>
<li class="menu-1259 menuparent  menu-path-node-82626  even "><a href="/about" title="">About</a><ul><li class="menu-9686 menu-path-node-1652 first odd "><a href="/ag" title="">The Attorney General</a></li>
<li class="menu-1267 menu-path-node-82606  even "><a href="/doj/budget-and-performance" title="">Budget &amp; Performance</a></li>
<li class="menu-51706 menu-path-node-632231  odd "><a href="/about/history" title="">History</a></li>
<li class="menu-89781 menu-path-node-1666  even last"><a href="/opcl" title="">Privacy Program</a></li>
</ul></li>
<li class="menu-1260 menuparent  menu-path-node-33666-chart  odd "><a href="/agencies/chart" title="">Agencies</a><ul><li class="menu-90596 menu-path-node-33666-chart first odd "><a href="/agencies/chart" title="">Organizational Chart</a></li>
<li class="menu-90591 menu-path-node-924706  even last"><a href="/agencies/alphabetical-listing-components-programs-initiatives" title="">Alphabetical Listing</a></li>
</ul></li>
<li class="menu-1262 menuparent  menu-path-node-82271  even "><a href="/resources" title="">Resources</a><ul><li class="menu-92026 menu-path-node-82476 first odd "><a href="/grants" title="">Grants</a></li>
<li class="menu-1261 menu-path-node-82486  even "><a href="/business" title="">Business</a></li>
<li class="menu-1272 menu-path-justicegov-forms  odd "><a href="http://www.justice.gov/forms" title="">Forms</a></li>
<li class="menu-1273 menu-path-node-643761  even "><a href="/publications" title="">Publications</a></li>
<li class="menu-5306 menu-path-largecases  odd last"><a href="/largecases" title="">Information for Victims in Large Cases</a></li>
</ul></li>
<li class="menu-1263 menuparent  menu-path-node-24871  odd "><a href="/briefing-room" title="">News</a><ul><li class="menu-1276 menu-path-node-780336 first odd "><a href="/news" title="">Press Releases</a></li>
<li class="menu-1278 menu-path-node-890381  even "><a href="/public-schedule" title="">Public Schedule</a></li>
<li class="menu-1279 menu-path-node-665661  odd "><a href="/videos" title="">Videos</a></li>
<li class="menu-1280 menu-path-opa-galleries  even last"><a href="/opa/galleries" title="">Photos</a></li>
</ul></li>
<li class="menu-92596 menuparent  menu-path-node-865991  even "><a href="/careers" title="">Careers</a><ul><li class="menu-2925 menu-path-node-3643 first odd "><a href="/legal-careers">Legal Careers</a></li>
<li class="menu-3650 menu-path-node-796646  even "><a href="/careers/veteran-recruitment" title="">Veteran Recruitment</a></li>
<li class="menu-92601 menu-path-node-6001  odd last"><a href="/careers/disability-hiring" title="">Disability Hiring</a></li>
</ul></li>
<li class="menu-1265 menu-path-node-82636  odd last"><a href="/contact-us" title="">Contact</a></li>
</ul>
  </div>
</div>
  </div>
          </header>
  </div>

  <div class="l-lower">
    
    <div class="l-main-wrapper">
      <div class="l-main">
        <div class="site-info">
          <h2 class="element-invisible">You are here</h2><div class="breadcrumb"><a href="/">Home</a> &raquo; <a href="/opa">Office of Public Affairs</a> &raquo; <a href="/opa/pr">News</a></div>        </div>

                  <div class="pre-content clearfix">
              <div class="l-region l-region--pre-content">
    <div id="block-doj-sharing-doj-sharing" class="block block--doj-sharing block--doj-sharing-doj-sharing">
        <div class="block__content">
    <div class="doj-sharing" style="display:none;">
  <a id="doj-sharing-toggle" tabindex="0" title="Choose a social sharing platform">
    Share  </a>
  <ul>
    <li>
      <a href="http://www.facebook.com/sharer/sharer.php?u=https://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote" target="_blank" title="Share on Facebook" data-event-label="Share on Facebook">Facebook</a>
    </li>
    <li>
      <a href="http://twitter.com/intent/tweet?url=https://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote&amp;text=Abbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote" target="_blank" title="Share on Twitter" data-event-label="Share on Twitter">Twitter</a>
    </li>
    <li>
      <a href="https://plus.google.com/share?url=https://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote" target="_blank" title="Share on Google+" data-event-label="Share on Google+">Google+</a>
    </li>
    <li>
      <a href="http://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote&amp;title=Abbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote" target="_blank" title="Share on LinkedIn" data-event-label="Share on LinkedIn">LinkedIn</a>
    </li>
    <li>
      <a href="http://digg.com/submit?url=https://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote&amp;title=Abbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote" target="_blank" title="Share on Digg" data-event-label="Share on Digg">Digg</a>
    </li>
    <li>
      <a href="http://reddit.com/submit?url=https://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote&amp;title=Abbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote" target="_blank" title="Share on Reddit" data-event-label="Share on Reddit">Reddit</a>
    </li>
    <li>
      <a href="http://www.stumbleupon.com/submit?url=https://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote&amp;title=Abbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote" target="_blank" title="Share on StumbleUpon" data-event-label="Share on StumbleUpon">StumbleUpon</a>
    </li>
    <li>
      <a href="http://pinterest.com/pin/create/button/?url=https://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote&amp;media=https://www.justice.gov/sites/all/modules/features/doj_sharing/images/doj-seal-pin.png&amp;title=Abbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote" target="_blank" title="Share on Pinterest" data-event-label="Share on Pinterest">Pinterest</a>
    </li>
    <li>
      <a href="mailto:?to=&body=https://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote&subject=Abbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote" title="Email" data-event-label="Email">Email</a>
    </li>
  </ul>
</div>
  </div>
</div>
  </div>
          </div>
        
        
        <div class="l-content" role="main">
                    <a id="main-content" tabindex="-1"></a>
                                <h1>Justice News</h1>
                    
          
                                        

<article about="/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote" typeof="sioc:Item foaf:Document" role="article" class="node node--press-release node--full node--press-release--full">
      <header>
                  <span property="dc:title" content="Abbott Labs to Pay $1.5 Billion to Resolve Criminal &amp; Civil Investigations of Off-label Promotion of Depakote" class="rdf-meta element-hidden"></span>    </header>
  
  
  <div class="node__content">
    
          <div class="pr-header">
        <div class="department">Department of Justice</div>
        <div class="agency">Office of Public Affairs</div>
      </div>
      <hr>
      <div class="pr-info">
        <div class="urgency-state">FOR IMMEDIATE RELEASE</div>
        <div class="field field--name-field-pr-date field--type-datetime field--label-hidden"><div class="field__items"><div class="field__item even"><span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2012-05-07T00:00:00-04:00">Monday, May 7, 2012</span></div></div></div>      </div>
      <h1 id="node-title">Abbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote</h1>
              <h2 id="node-subtitle" class="center"><div class="field field--name-field-pr-subtitle field--type-text field--label-hidden"><div class="field__items"><div class="field__item even">Company Maintained Specialized Sales Force to Market Drug for Off Label Purposes; Targeted Elderly Dementia Patients in Nursing Homes</div></div></div></h2>
              <div class="field field--name-field-pr-body field--type-text-long field--label-hidden"><div class="field__items"><div class="field__item even"><p>Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the companys unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Justice Department announced today. The resolution  the second largest payment by a drug company  includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbotts CEO and Board of Directors.</p>

<p>Todays settlement shows further evidence of our deep commitment to public health and our determination to hold accountable those who commit fraud, said James M. Cole, Deputy Attorney General. We are resolute in stopping this type of activity and todays settlement sends a strong message to other companies.</p>

<p></p>

<p>The FDA is responsible for approving drugs as safe and effective for specified uses. Under the Food, Drug and Cosmetic Act (FDCA), a company in its application to the FDA must specify each intended use of a drug. A companys promotional activities must be limited to only the intended uses that FDA approved. In fact, promotion by the manufacturer for other uses  known as off-label uses  renders the product misbranded.</p>

<p></p>

<p>Abbott has pleaded guilty to misbranding Depakote by promoting the drug to control agitation and aggression in elderly dementia patients and to treat schizophrenia when neither of these uses was FDA approved. In an agreed statement of facts filed in the criminal action, Abbott admits that from 1998 through 2006, the company maintained a specialized sales force trained to market Depakote in nursing homes for the control of agitation and aggression in elderly dementia patients, despite the absence of credible scientific evidence that Depakote was safe and effective for that use. In addition, from 2001 through 2006, the company marketed Depakote in combination with atypical antipsychotic drugs to treat schizophrenia, even after its clinical trials failed to demonstrate that adding Depakote was any more effective than an atypical antipsychotic alone for that use.</p>

<p><u>Illegal Promotion of Depakote to Control Agitation and Aggression in Dementia Patients</u></p>

<p>The FDA approved Depakote for only three uses:epileptic seizures, bipolar mania and the prevention of migraines. The FDA never approved the drug as safe and effective for the off-label use of controlling behavioral disturbances in dementia patients. In 1999, Abbott was forced to discontinue a clinical trial of Depakote in the treatment of dementia due to an increased incidence of adverse events, including somnolence, dehydration and anorexia experienced by the elderly study participants administered Depakote.</p>

<p>Abbott trained its sales force to promote Depakote to health care providers and employees of nursing homes as advantageous over antipsychotic drugs for controlling agitation and aggression in elderly dementia patients because Depakote was not subject to certain provisions of the Omnibus Budget Reconciliation Act of 1987 (OBRA) and its implementing regulations designed to prevent the use of unnecessary medications in nursing homes. Exploiting the fact that certain OBRA provisions did not yet apply to Depakote, Abbott sales <span style="color:rgb(0, 0, 0)"> representatives stated that by using Depakote, nursing homes could avoid the administrative burdens and costs of complying with OBRA.</span></p>

<p></p>

<p>Abbotts off-label promotion of Depakote was multifaceted. The company entered into contracts that provided long-term care pharmacy providers with payments of rebates based on increases in the use of Depakote in nursing homes serviced by the providers. In addition to using its sales force to promote the drug to health care providers and employees of nursing homes, Abbott created programs and materials to train the pharmacy providers consultant pharmacists about the off-label use of Depakote to encourage them to recommend the drug for this unapproved use. Under these contracts, Abbott paid millions of dollars in rebates to the pharmacy providers.</p>

<p></p>

<p>Not only did Abbott engage in off-label promotion, but it targeted elderly dementia patients and downplayed the risks apparent from its own clinical studies, said <span style="color:rgb(0, 0, 0)"> Acting Associate Attorney General Tony West.</span> As this criminal and civil resolution demonstrates, those who put profits ahead of patients will pay a hefty price.</p>

<p></p>

<p><u>Illegal Off-Label Promotion of Depakote for Schizophrenia</u></p>

<p></p>

<p>In the agreed statement of facts, Abbott also admitted that from 2001 through 2006, the Company misbranded Depakote by marketing the drug to treat schizophrenia. Abbott funded two studies of the use of Depakote to treat schizophrenia, and both failed to meet the main goals established for the study. When the second study failed to show a statistically significant treatment difference between antipsychotic drugs used in combination with Depakote and antipsychotic drugs alone, Abbott waited nearly two years to notify its own sales force about the study results and another two years to publish those results. During this time, Abbott continued to promote Depakote off-label to treat schizophrenia.</p>

<p></p>

<p> <span style="color:rgb(0, 0, 0)"> Todays settlement demonstrates our continued scrutiny of the sales and marketing practices of pharmaceutical companies that putprofits ahead of patient health, said U.S. Food and Drug Administration Commissioner Margaret Hamburg, M.D. The FDA will continue its due diligence and hold pharmaceutical companies accountable formarketing practices that undermine thedrug approval process.</span></p>

<p></p>

<p><u>Criminal Plea</u></p>

<p></p>

<p>Todays global resolution has criminal, civil and administrative components. First, Abbott has pleaded guilty to a criminal misdemeanor for misbranding Depakote in violation of the FDCA. Under the plea agreement, Abbott will pay a criminal fine of $500 million, forfeit assets of $198.5 million, and submit to a term of probation for five years. In addition, Abbott will also pay $1.5 million to the Virginia Medicaid Fraud Control Unit. As a condition of probation, Abbott will report any probable FDCA violations to the probation office, its CEO will certify compliance with this reporting requirement, and its board will report annually on the effectiveness of the companys compliance program. In addition, Abbott agrees that during the term of probation, the company will not compensate sales representatives for off-label sales, will ensure that continuing medical education grant-making decisions are not controlled by sales and marketing, will require that letters communicating medical information to healthcare providers be accurate and unbiased, and will have policies designed to ensure that clinical trials are approved by the companys medical or scientific organizations and published in a consistent and transparent manner. Abbotts guilty plea and sentence are not final until accepted by the U.S. District Court for the Western District of Virginia.</p>

<p></p>

<p>As the agreed statement of facts filed in court today demonstrates, Abbott promoted Depakote to control behaviors in elderly dementia and schizophrenia patients without significant evidence of its effectiveness for that use, and even after clinical data established that it was not effective, said Timothy Heaphy, U.S. Attorney for the Western District of Virginia. The resolution announced today includes a self-policing mechanism by which Abbotts board of directors will monitor compliance with the law and report any violations, as well as a period of probation and court supervision. We credit Abbotts acceptance of responsibility and encourage other pharmaceutical companies to impose the similar mechanisms to prevent off-label marketing, which damages health care consumers.</p>

<p></p>

<p><u>Civil Settlement</u></p>

<p></p>

<p>Under the civil settlement, Abbott has agreed to pay $800 million to the federal government ($560,851,357) and the states ($239,148,643) that opt to participate in the agreement to resolve claims that its unlawful marketing and illegal remuneration practices caused false claims to be submitted to government health care programs such as Medicare, Medicaid, TRICARE and to the Federal Employees Health Benefit Program, the Department of Veterans Affairs and the Department of Labors Office of Workers Compensation Programs.</p>

<p></p>

<p>The civil settlement addresses broader allegations by the United States that from 1998 through 2008, Abbott unlawfully promoted Depakote for unapproved uses, including behavioral disturbances in dementia patients, psychiatric conditions in children and adolescents, schizophrenia, depression, anxiety, conduct disorders, obsessive-compulsive disorder, post-traumatic stress disorder, alcohol and drug withdrawal, attention deficit disorder and autism. . Some of these unapproved uses were not medically accepted indications for which the United States and state Medicaid programs provided coverage for Depakote. The United States contends that this promotion included, in part, making false and misleading statements about the safety, efficacy, dosing and cost-effectiveness of Depakote for some of these unapproved uses, and claiming use of Depakote to control behavioral disturbances in dementia patients would help nursing homes avoid the administrative burdens and costs of complying with OBRA regulatory restrictions applicable to antipsychotics.</p>

<p></p>

<p>The civil settlement also covers allegations that Abbott offered and paid illegal remuneration to health care professionals and long term care pharmacy providers to induce them to promote and/or prescribe Depakote and to improperly and unduly influence the content of company sponsored Continuing Medical Education programs, in violation of the Federal Anti-Kickback Statute. The claims settled by the civil agreement are allegations only and there has been no determination of liability, except to the extent that Abbott has admitted facts in the civil settlement agreement or in the criminal plea and agreed statement of facts filed in the criminal action.</p>

<p></p>

<p>The civil settlement resolves four lawsuits pending in federal court in the Western District of Virginia under the <em>qui tam</em>, or whistleblower, provisions of the False Claims Act, which allow private citizens to bring civil actions on behalf of the United States and share in any recovery. As part of todays resolution, the whistleblowers will receive $84 million from the federal share of the settlement amount.</p>

<p></p>

<p><u>Corporate Integrity Agreement</u></p>

<p></p>

<p>In addition to the criminal and civil resolutions, Abbott has also executed a Corporate Integrity Agreement (CIA) with the Department of Health and Human Services, Office of Inspector General (HHS-OIG). The five-year CIA requires, among other things, that Abbott's board of directors review the effectiveness of the company's compliance program, that high-level executives certify to compliance, that Abbott maintain standardized risk assessment and mitigation processes, and that the company post on its website information about payments to doctors. Abbott is subject to exclusion from federal health care programs, including Medicare and Medicaid, for a material breach of the CIA and subject to monetary penalties for less significant breaches.</p>

<p></p>

<p>As a result of OIGs joint investigation with our federal and state partners, Abbott Laboratories will enter one of the pharmaceutical industrys largest settlements and pay $1.5 billion for unlawfully promoting its drug Depakote, including to nursing home patients with dementia, said HHS Inspector General Daniel R. Levinson. Our integrity agreement will hold Abbott accountable for preventing future violations of federal health care laws and FDA requirements, which will protect federal programs, taxpayers and our most vulnerable patients.</p>

<p></p>

<p><u>A Multilateral Effort</u></p>

<p></p>

<p>The criminal case is being prosecuted by the U.S. Attorneys Office for the Western District of Virginia and the Civil Divisions Consumer Protection Branch. The civil settlement was reached by the U.S. Attorneys Office for the Western District of Virginia and the Civil Divisions Commercial Litigation Branch. Assistance w <span style="color:rgb(0, 0, 0)"> as provided by representatives of the HHS Office of Counsel to the Inspector General; the Center for Medicare and Medicaid Services (CMS) and Office of the General Counsel, CMS Division; FDAs Office of Chief Counsel; and the National Association of Medicaid Fraud Control Units.</span></p>

<p></p>

<p>Crimes involving the misbranding of drugs for financial gain will not be tolerated, stated Richard Weber, Chief IRS Criminal Investigation. The special agents of IRS Criminal Investigation will use all their investigative tools, including the use of asset forfeiture statutes, to combat financial crimes and hold corporations accountable for their actions.</p>

<p></p>

<p>This matter was investigated by the Virginia Attorney Generals Medicaid Fraud Control Unit; the Internal Revenue Service - Criminal Investigation; the FDA - Office of Criminal Investigation; the Defense Criminal Investigative Service; the Health and Human Services - Office of Inspector General; the West Virginia State Police; the Office of Personnel Management - Office of Inspector General; the Department of Veterans Affairs Office of Inspector General; the Department of Labor - Office of Inspector General; and TRICARE Program Integrity.</p>

<p></p>

<p>This resolution is part of the government's emphasis on combating health care fraud and another step for the Health Care Fraud Prevention and Enforcement Action Team (HEAT) initiative, which was announced in May 2009 by Attorney General Eric Holder and Kathleen Sebelius, Secretary of HHS. The partnership between the two departments has focused efforts to reduce and prevent Medicare and Medicaid financial fraud through enhanced cooperation. One of the most powerful tools in that effort is the False Claims Act, which the Justice Department has used to recover more than $7.4 billion since January 2009 in cases involving fraud against federal health care programs. With the settlement announced today, the Justice Department's total recoveries in False Claims Act cases since January 2009 will exceed $10.2 billion. During this same time, the department has secured $3.9 billion in criminal fines, forfeiture, disgorgement, and restitution relating to violations of the FDCA.</p>

<h4>Related Materials:</h4>

<p><a href="http://www.justice.gov/opa/abbott-labs-docs.html">Court Documents Related to Settlement with Abbott Laboratories</a><br /><a href="http://www.justice.gov/iso/opa/dag/speeches/2012/dag-speech-120507.html">Remarks By Deputy Attorney James M. Cole Regarding Settlement with Abbott Laboratories</a><br /><a href="http://www.justice.gov/iso/opa/civil/speeches/2012/civ-speech-120507.html">Remarks By Acting Associate Attorney General Tony West Regarding Settlement with Abbott Laboratories</a><br /><a href="http://www.justice.gov/css-gallery/gallery-abbott-lab.html">Press Conference Photo Gallery</a></p>
</div></div></div>    <div class="pr-fields">
      <div class="field field--name-field-pr-topic field--type-taxonomy-term-reference field--label-above"><div class="field__label">Topic(s):&nbsp;</div><div class="field__items"><div class="field__item even">Consumer Protection</div></div></div><div class="field field--name-field-pr-component field--type-taxonomy-term-reference field--label-above"><div class="field__label">Component(s):&nbsp;</div><div class="field__items"><div class="field__item even"><a href="http://www.justice.gov/civil/" typeof="skos:Concept" property="rdfs:label skos:prefLabel" datatype="">Civil Division</a></div></div></div><div class="field field--name-field-pr-number field--type-text field--label-above"><div class="field__label">Press Release Number:&nbsp;</div><div class="field__items"><div class="field__item even">12-585</div></div></div>    </div>
  </div>

      <div class="node__updated">Updated October 22, 2014</div>
</article>
                  </div>

          <aside class="l-region l-region--sidebar-second">
    <div id="block-views-og-sidebar-block-sitewide" class="block block--views block--views-og-sidebar-block-sitewide">
        <div class="block__content">
    <div class="view view-og-sidebar view-id-og_sidebar view-display-id-block_sitewide view-dom-id-01a173002ea199c60667fe3d938e2306 views-display-type-block">
        
  
  
      <div class="view-content">
        <div class="views-row views-row-1 views-row-odd views-row-first views-row-last">
    <div class="panelizer-view-mode node node-full node-sidebar node-753">
        <div class="astraea panel-astraea panel-display--astraea">
  <div class="panels-region-wrapper astraea-region astraea-region--content">
    <div class="panel-pane pane-fieldable-panels-pane pane-uuid-8c0cfd94-19c6-4ca7-b15d-960ce1fd79be pane-bundle-quick-links panels-pane-style-gold-double">
  <div class="panel-pane-inner">
                        <div class="fieldable-panels-pane" class="fieldable-panels-pane">
    <div class="field field--name-field-ql-image field--type-image field--label-hidden"><div class="field__items"><div class="field__item even"><img typeof="foaf:Image" src="https://www.justice.gov/sites/default/files/images/quick_links/action-center_0.jpg" width="227" height="108" /></div></div></div>
<div class="field field--name-field-ql-links field--type-link-field field--label-hidden">
    <div class="field__items">
    <div class="first-half">
              <div class="field__item even">
          <a href="https://www.justice.gov/actioncenter/report-crime">Report a Crime</a>        </div>
              <div class="field__item odd">
          <a href="https://www.justice.gov/careers">Get a Job</a>        </div>
              <div class="field__item even">
          <a href="https://www.justice.gov/actioncenter/locate-prison-inmate-or-sex-offender">Locate a Prison, Inmate, or Sex Offender</a>        </div>
              <div class="field__item odd">
          <a href="https://www.justice.gov/grants">Apply for a Grant</a>        </div>
              <div class="field__item even">
          <a href="https://www.justice.gov/actioncenter/submit-complaint">Submit a Complaint</a>        </div>
              <div class="field__item odd">
          <a href="https://oig.justice.gov/hotline/">Report Waste, Fraud, Abuse or Misconduct to the Inspector General</a>        </div>
              <div class="field__item even">
          <a href="https://www.justice.gov/actioncenter/find-sales-seized-property">Find Sales of Seized Property</a>        </div>
          </div>
    <div class="second-half">
              <div class="field__item even">
          <a href="https://www.justice.gov/actioncenter/find-help-and-information-crime-victims">Find Help and Information for Crime Victims</a>        </div>
              <div class="field__item odd">
          <a href="https://www.justice.gov/actioncenter/register-apply-permits-or-request-records-0">Register, Apply for Permits, or Request Records</a>        </div>
              <div class="field__item even">
          <a href="https://www.justice.gov/actioncenter/identify-our-most-wanted-fugitives">Identify Our Most Wanted Fugitives</a>        </div>
              <div class="field__item odd">
          <a href="https://www.justice.gov/forms/dojform.php">Find a Form</a>        </div>
              <div class="field__item even">
          <a href="https://www.justice.gov/actioncenter/report-and-identify-missing-persons">Report and Identify Missing Persons</a>        </div>
              <div class="field__item odd">
          <a href="https://www.justice.gov/contact-us">Contact Us</a>        </div>
          </div>
  </div>
</div>
</div>
          </div>
</div>
<div class="panel-pane pane-fieldable-panels-pane pane-uuid-9f7f030c-af1a-4584-bdae-c9d694a23821 pane-bundle-image">
  <div class="panel-pane-inner">
                        <div class="fieldable-panels-pane" class="fieldable-panels-pane">
    <div class="field field--name-field-image-pane-image field--type-image field--label-hidden"><div class="field__items"><div class="field__item even"><a href="http://www.justice.gov/usao"><img typeof="foaf:Image" src="https://www.justice.gov/sites/default/files/image_panes/images/usao.jpg" width="268" height="95" alt="" /></a></div></div></div></div>
          </div>
</div>
  </div>
</div>
</div>
  </div>
    </div>
  
  
  
  
  
  
</div>  </div>
</div>
  </aside>
      </div>
      <!-- /.l-main -->
    </div>
    <!-- /.l-main-wrapper -->
  </div>
  <!-- /.l-lower -->

  <div class="l-footer-wrapper">
    <footer class="l-footer" role="contentinfo">
        <div class="l-region l-region--footer">
    <nav id="block-menu-menu-footer-secondary-menu" role="navigation" class="block block--menu block--menu-menu-footer-secondary-menu">
        <h2 class="block__title">JUSTICE.GOV</h2>
    
  <ul class="menu"><li class="first expanded"><span class="nolink">Left Column</span><ul class="menu"><li class="first leaf"><a href="http://www.justice.gov/archive">Archive</a></li>
<li class="leaf"><a href="/accessibility/accessibility-information" title="">Accessibility</a></li>
<li class="leaf"><a href="http://get.adobe.com/reader/otherversions/" title="">Adobe Reader</a></li>
<li class="leaf"><a href="/oip" title="">FOIA</a></li>
<li class="leaf"><a href="/jmd/eeo-program-status-report" title="">No FEAR Act</a></li>
<li class="leaf"><a href="/iqpr/information-quality" title="">Information Quality</a></li>
<li class="leaf"><a href="/doj/privacy-policy" title="">Privacy Policy</a></li>
<li class="last leaf"><a href="/legalpolicies" title="">Legal Policies &amp; Disclaimers</a></li>
</ul></li>
<li class="last expanded"><span class="nolink">Right Column</span><ul class="menu"><li class="first leaf"><a href="/social" title="">Social Media</a></li>
<li class="leaf"><a href="/employees" title="">For Employees</a></li>
<li class="leaf"><a href="http://www.justice.gov/oig">Office of the Inspector General</a></li>
<li class="leaf"><a href="/open" title="">Open Government</a></li>
<li class="leaf"><a href="/open/plain-writing-act" title="">Plain Writing</a></li>
<li class="leaf"><a href="http://usa.gov">USA.gov</a></li>
<li class="last leaf"><a href="http://business.usa.gov/">BusinessUSA</a></li>
</ul></li>
</ul></nav>
<div id="block-block-2" class="block block--block block--block-2">
        <div class="block__content">
    <p><img alt="DOJ" style="float:left;" src="/sites/all/themes/justice/images/us-doj-logo-text-new.png" />| 950<strong>Pennsylvania Avenue</strong>, NW Washington, DC 20530-0001</p>
  </div>
</div>
<nav id="block-menu-menu-footer-menu" role="navigation" class="block block--menu block--menu-menu-footer-menu">
        <h2 class="block__title">Footer Menu</h2>
    
  <ul class="menu"><li class="first expanded"><span class="nolink">Left Column</span><ul class="menu"><li class="first expanded"><a href="/about" title="">ABOUT</a><ul class="menu"><li class="first leaf"><a href="/ag" title="">The Attorney General</a></li>
<li class="leaf"><a href="/doj/budget-and-performance" title="">Budget &amp; Performance</a></li>
<li class="leaf"><a href="/about/history" title="">History</a></li>
<li class="last leaf"><a href="/opcl" title="">Privacy Program</a></li>
</ul></li>
<li class="last expanded"><a href="/agencies/chart" title="">AGENCIES</a><ul class="menu"><li class="first leaf"><a href="/agencies/chart" title="">Organizational Chart</a></li>
<li class="last leaf"><a href="/agencies/alphabetical-listing-components-programs-initiatives" title="">Alphabetical Listing</a></li>
</ul></li>
</ul></li>
<li class="expanded"><span class="nolink">Middle Column</span><ul class="menu"><li class="first expanded"><a href="/resources" title="">RESOURCES</a><ul class="menu"><li class="first leaf"><a href="/grants" title="">Grants</a></li>
<li class="leaf"><a href="/business" title="">Business</a></li>
<li class="leaf"><a href="http://www.justice.gov/forms" title="">Forms</a></li>
<li class="leaf"><a href="/publications" title="">Publications</a></li>
<li class="last leaf"><a href="http://www.justice.gov/largecases/" title="Information for Victims in Large Cases">Information for Victims in Large Cases</a></li>
</ul></li>
<li class="last expanded"><a href="/briefing-room" title="">NEWS</a><ul class="menu"><li class="first leaf"><a href="/news" title="">Press Releases</a></li>
<li class="leaf"><a href="/public-schedule" title="">Public Schedule</a></li>
<li class="leaf"><a href="/videos" title="">Videos</a></li>
<li class="last leaf"><a href="http://www.justice.gov/opa/galleries" title="">Photos</a></li>
</ul></li>
</ul></li>
<li class="last expanded"><span class="nolink">Right Column</span><ul class="menu"><li class="first expanded"><a href="/careers" title="">CAREERS</a><ul class="menu"><li class="first leaf"><a href="/legal-careers" title="">Legal Careers</a></li>
<li class="leaf"><a href="/careers/veteran-recruitment" title="">Veteran Recruitment</a></li>
<li class="last leaf"><a href="/careers/disability-hiring" title="">Disability Hiring</a></li>
</ul></li>
<li class="last leaf"><a href="/contact-us" title="">CONTACT</a></li>
</ul></li>
</ul></nav>
  </div>
    </footer>
  </div>
</div>

  <script type="text/javascript" src="//ajax.googleapis.com/ajax/libs/jquery/1.7.2/jquery.min.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
window.jQuery||document.write("<script src='/sites/all/modules/contrib/jquery_update/replace/jquery/1.7/jquery.min.js'>\x3C/script>");
//--><!]]>
</script>
<script type="text/javascript" src="https://www.justice.gov/sites/default/files/advagg_js/js__q0X56UwREcbJyzNybeawxQuz29PS0RVFWTYH2h61iGo__djjoHl6BGDusxBd2H_7L3zvUFs7u2nVqOwQ_6Uid4Ek__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.js"></script>
<script type="text/javascript" src="//ajax.googleapis.com/ajax/libs/jqueryui/1.10.2/jquery-ui.min.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
window.jQuery.ui||document.write("<script src='/sites/all/modules/contrib/jquery_update/replace/ui/ui/minified/jquery-ui.min.js'>\x3C/script>");
//--><!]]>
</script>
<script type="text/javascript" src="https://www.justice.gov/sites/default/files/advagg_js/js__P2rLh1v2LkaimiTzQTjBZc1Vd2S--nSe5qfO4nPm4fI__7WJsicGBq887YQcKYBvGYsHw6HVr__II83PtyHK5WzA__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.js"></script>
<script type="text/javascript" src="https://www.justice.gov/sites/all/libraries/mediaelement/build/mediaelement-and-player.min.js?v=2.1.6"></script>
<script type="text/javascript" src="https://www.justice.gov/sites/default/files/advagg_js/js__HeBlbfZg31W5-k3TnSu0psp6NxEebwWqfnnTeMENJc0__0pHO0iklafpAGQz1-symT5ZS590wnV0-uwvdq3VFa80__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.js"></script>

<!--[if (gte IE 6)&(lte IE 8)]>
<script type="text/javascript" src="https://www.justice.gov/sites/default/files/advagg_js/js__UBTbecLPXcFRDNR3XjnGaFARkN87O-WXu18yLu6P1NE__YxqvutpREDoNXz22Aw7c17BIVoeHmcVG_xEpS91m3mU__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.js"></script>
<![endif]-->
<script type="text/javascript" src="https://www.justice.gov/sites/default/files/advagg_js/js__dljmKJjRlpPG5g8lmwa5Kg6T5UcOzbq5u1Pd-VLTKtk__p1ugmCg_rIauAUC_nT6m3W1TC8XqtSqXx9ZVYWisyWo__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","autocomplete_limit":{"limit":2},"colorbox":{"transition":"none","speed":"350","opacity":"0.85","slideshow":true,"slideshowAuto":true,"slideshowSpeed":"6000","slideshowStart":"start slideshow","slideshowStop":"stop slideshow","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","overlayClose":true,"returnFocus":true,"maxWidth":"98%","maxHeight":"98%","initialWidth":"300","initialHeight":"500","fixed":true,"scrolling":true,"mobiledetect":false,"mobiledevicewidth":"480px"},"nice_menus_options":{"delay":"800","speed":"fast"},"mediaelementAll":true,"better_exposed_filters":{"views":{"doj_banner":{"displays":{"block":{"filters":[]}}},"og_sidebar":{"displays":{"block_sitewide":{"filters":[]}}}}},"responsive_menus":[{"selectors":".responsive .block--nice-menus .block__content, .responsive .l-region--navigation .block__content","container":"body","trigger_txt":"\u003Cspan \/\u003E\u003Cspan \/\u003E\u003Cspan \/\u003E","close_txt":"X","close_size":"18px","position":"right","media_size":"704","show_children":"1","expand_children":"1","expand_txt":"+","contract_txt":"-","remove_attrs":"1","responsive_menus_style":"mean_menu"}],"tablesorter":{"zebra":1,"odd":"odd","even":"even"},"extlink":{"extTarget":0,"extClass":"ext","extLabel":"(link is external)","extImgClass":0,"extSubdomains":1,"extExclude":"\\.(gov|mil|fed\\.us)(\\\/.*)?$","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":"_blank","extAlertText":{"value":"The Department of Justice does not endorse the organizations or views represented by this site and takes no responsibility for, and exercises no control over, the accuracy, accessibility, copyright or trademark compliance or legality of the material contained on this site.\n\nThank you for visiting our site.","format":"full_html"},"mailtoClass":"mailto","mailtoLabel":"(link sends e-mail)"},"extlink_extra":{"extlink_alert_type":"colorbox","extlink_alert_type_colorbox_mobile":"confirm","extlink_alert_text_colorbox_mobile":"You are now leaving a Department of Justice Web site. You are about to access:\n\n[extlink:external-url]\n\nThe Department of Justice does not endorse the organizations or views represented by this site and takes no responsibility for, and exercises no control over, the accuracy, accessibility, copyright or trademark compliance or legality of the material contained on this site.\n\nThank you for visiting our site.","extlink_alert_timer":"4","extlink_alert_url":"\/now-leaving?js=1","extlink_cache_fix":1,"extlink_exclude_warning":"","extlink_508_fix":1,"extlink_508_text":" [external link]","extlink_url_override":0,"extlink_url_params":{"external_url":null,"back_url":null}},"urlIsAjaxTrusted":{"https:\/\/search.justice.gov\/search":true},"ogContext":{"groupType":"node","gid":"1664"},"ajaxPageState":{"js":{"sites\/all\/modules\/contrib\/extlink_extra\/extlink_extra.js":1,"sites\/all\/modules\/contrib\/responsive_tables_filter\/tablesaw\/js\/tablesaw.stackonly.js":1,"sites\/all\/modules\/contrib\/responsive_tables_filter\/tablesaw\/js\/tablesaw-init.js":1,"sites\/all\/libraries\/jquery.event.move\/js\/jquery.event.move.js":1,"sites\/all\/libraries\/jquery.event.swipe\/js\/jquery.event.swipe.js":1,"sites\/all\/modules\/contrib\/colorbox_swipe\/colorbox_swipe.js":1,"\/\/ajax.googleapis.com\/ajax\/libs\/jquery\/1.7.2\/jquery.min.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/no-js.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/external\/jquery.cookie.js":1,"\/\/ajax.googleapis.com\/ajax\/libs\/jqueryui\/1.10.2\/jquery-ui.min.js":1,"sites\/all\/themes\/justice\/js\/justice.early-behaviors.js":1,"sites\/all\/modules\/contrib\/nice_menus\/js\/jquery.bgiframe.js":1,"sites\/all\/libraries\/jquery.hoverIntent\/jquery.hoverIntent.js":1,"sites\/all\/modules\/contrib\/nice_menus\/js\/superfish.js":1,"sites\/all\/modules\/contrib\/nice_menus\/js\/nice_menus.js":1,"sites\/all\/libraries\/mediaelement\/build\/mediaelement-and-player.min.js":1,"misc\/form.js":1,"sites\/all\/modules\/contrib\/tablesorter\/tablesortervar.js":1,"sites\/all\/modules\/contrib\/extlink\/extlink.js":1,"sites\/all\/themes\/justice\/libraries\/html5shiv\/html5shiv.min.js":1,"sites\/all\/themes\/justice\/libraries\/html5shiv\/html5shiv-printshiv.min.js":1,"sites\/all\/themes\/justice\/libraries\/selectivizr\/selectivizr.min.js":1,"sites\/all\/libraries\/colorbox\/jquery.colorbox-min.js":1,"sites\/all\/modules\/contrib\/colorbox\/js\/colorbox.js":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.js":1,"sites\/all\/modules\/custom\/doj_analytics\/js\/doj_analytics_events.js":1,"sites\/all\/libraries\/mapify\/build\/jquery.mapify.js":1,"sites\/all\/modules\/contrib\/mediaelement\/mediaelement.js":1,"sites\/all\/modules\/features\/doj_image_map\/js\/doj_image_map_mapify.js":1,"sites\/all\/modules\/contrib\/responsive_menus\/styles\/meanMenu\/jquery.meanmenu.min.js":1,"sites\/all\/modules\/contrib\/responsive_menus\/styles\/meanMenu\/responsive_menus_mean_menu.js":1,"sites\/all\/libraries\/tablesorter\/jquery.tablesorter.min.js":1,"sites\/all\/libraries\/tablesorter\/jquery.metadata.js":1,"sites\/all\/libraries\/tablesorter\/addons\/pager\/jquery.tablesorter.pager.js":1,"misc\/collapse.js":1,"sites\/all\/modules\/features\/doj_sharing\/js\/doj_sharing.js":1,"sites\/all\/modules\/features\/doj_media\/js\/doj_media.colorbox.js":1,"sites\/all\/modules\/features\/doj_shortcode\/js\/jumpmenu.js":1,"sites\/all\/modules\/features\/doj_image_pane\/doj_image_pane.js":1,"sites\/all\/themes\/justice\/js\/justice.behaviors.js":1}}});
//--><!]]>
</script>
  <script type="text/javascript" src="https://www.justice.gov/sites/default/files/advagg_js/js__7By10u7uYYvSywdJUkrylttXj14EhgtaUf3-fDA8IhE__HBrQCUVyCkCJhNWkn6mDS0Ab3sRSYIiAVZlOlGbTrQw__XTs8YUM4IDpqkSA6YxXn2rbqwigbbu3ifZBqw3X4O4M.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var usasearch_config={siteHandle:'justice'};
//--><!]]>
</script>
</body>
</html>
